Barclays’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Buy |
|
|||||
|
2025
Q1 | $526K | Sell |
|
|||||
|
2024
Q4 | $528K | Buy |
|
|||||
|
2024
Q3 | $442K | Buy |
|
|||||
|
2024
Q2 | $88K | Sell |
|
|||||
|
2024
Q1 | $223K | Sell |
|
|||||
|
2023
Q4 | $357K | Buy |
|
|||||
|
2023
Q3 | $45K | Sell |
|
|||||
|
2023
Q2 | $59K | Sell |
|
|||||
|
2023
Q1 | $131K | Buy |
|
|||||
|
2022
Q4 | $69K | Buy |
|
|||||
|
2022
Q3 | $9K | Sell |
|
|||||
|
2022
Q2 | $10K | Sell |
|
|||||
|
2022
Q1 | $145K | Sell |
|
|||||
|
2021
Q4 | $550K | Sell |
|
|||||
|
2021
Q3 | $1.3M | Buy |
|
|||||
|
2021
Q2 | $1.03M | Sell |
|
|||||
|
2021
Q1 | $1.45M | Buy |
|
|||||
|
2020
Q4 | $538K | Sell |
|
|||||
|
2020
Q3 | $441K | Sell |
|
|||||
|
2020
Q2 | $456K | Buy |
|
|||||
|
2020
Q1 | $325K | Sell |
|
|||||
|
2019
Q4 | $526K | Buy |
|
|||||
|
2019
Q3 | $392K | Buy |
|
|||||
|
2019
Q2 | $442K | Buy |
|
|||||
|
2019
Q1 | $278K | Buy |
|
|||||
|
2018
Q4 | $230K | Sell |
|
|||||
|
2018
Q3 | $866K | Sell |
|
|||||
|
2018
Q2 | $1.66M | Sell |
|
|||||
|
2018
Q1 | $3.28M | Buy |
|
|||||
|
2017
Q4 | $1.65M | Buy |
|
|||||
|
2017
Q3 | $427K | Buy |
|
|||||
|
2017
Q2 | $446K | Buy |
|
|||||
|
2017
Q1 | $106K | Sell |
|
|||||
|
2016
Q4 | $105K | Buy |
|
|||||
|
2016
Q3 | $137K | Sell |
|
|||||
|
2016
Q2 | $178K | Buy |
|
|||||
|
2016
Q1 | $94K | Buy |
|
|||||
|
2015
Q4 | $6K | Buy |
|
|||||
|
2015
Q3 | $2K | Sell |
|
|||||
|
2015
Q2 | $58K | Buy |
|
|||||
|
2015
Q1 | $29K | Sell |
|
|||||
|
2014
Q4 | $40K | Sell |
|
|||||
|
2014
Q3 | $48K | Buy |
|
|||||
|
2014
Q2 | $90K | Sell |
|
|||||
|
2014
Q1 | $156K | Buy |
|
|||||
|
2013
Q4 | $64K | Buy |
|
|||||
|
2013
Q3 | $94K | Sell |
|
|||||
|
2013
Q2 | $139K | Buy |
|